- Home
- Publications
- Publication Search
- Publication Details
Title
Brodalumab: A Review in Moderate to Severe Plaque Psoriasis
Authors
Keywords
-
Journal
DRUGS
Volume 78, Issue 4, Pages 495-504
Publisher
Springer Nature
Online
2018-03-08
DOI
10.1007/s40265-018-0888-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Psychiatric adverse events during treatment with brodalumab: Analysis of psoriasis clinical trials
- (2018) Mark G. Lebwohl et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- European S3-Guideline on the systemic treatment of psoriasis vulgaris - Update Apremilast and Secukinumab - EDF in cooperation with EADV and IPC
- (2017) A. Nast et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Early relapse of psoriasis after stopping brodalumab: a retrospective cohort study in 77 patients
- (2017) M. Masson Regnault et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- A prospective phase III, randomized, double-blind, placebo-controlled study of brodalumab in patients with moderate-to-severe plaque psoriasis
- (2016) K.A. Papp et al. BRITISH JOURNAL OF DERMATOLOGY
- Anti-IL-17 Medications Used in the Treatment of Plaque Psoriasis and Psoriatic Arthritis: A Comprehensive Review
- (2015) Theresa N. Canavan et al. AMERICAN JOURNAL OF CLINICAL DERMATOLOGY
- The Psychological Burden of Skin Diseases: A Cross-Sectional Multicenter Study among Dermatological Out-Patients in 13 European Countries
- (2015) Florence J. Dalgard et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- European S3-Guidelines on the systemic treatment of psoriasis vulgaris - Update 2015 - Short version - EDF in cooperation with EADV and IPC
- (2015) A. Nast et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Phase 3 Studies Comparing Brodalumab with Ustekinumab in Psoriasis
- (2015) Mark Lebwohl et al. NEW ENGLAND JOURNAL OF MEDICINE
- Population pharmacokinetics of brodalumab in healthy adults and adults with psoriasis from single and multiple dose studies
- (2014) Christopher J. Endres et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Gene Expression Profiles Normalized in Psoriatic Skin by Treatment with Brodalumab, a Human Anti-IL-17 Receptor Monoclonal Antibody
- (2014) C. B. Russell et al. JOURNAL OF IMMUNOLOGY
- Anti-IL-17 Receptor Antibody AMG 827 Leads to Rapid Clinical Response in Subjects with Moderate to Severe Psoriasis: Results from a Phase I, Randomized, Placebo-Controlled Trial
- (2012) Kim A. Papp et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Brodalumab, an Anti–Interleukin-17–Receptor Antibody for Psoriasis
- (2012) Kim A. Papp et al. NEW ENGLAND JOURNAL OF MEDICINE
- Guidelines of care for the management of psoriasis and psoriatic arthritis
- (2011) Alan Menter et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Definition of treatment goals for moderate to severe psoriasis: a European consensus
- (2010) U. Mrowietz et al. ARCHIVES OF DERMATOLOGICAL RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now